Abnormal liver function is common in patients with COVID-19 (Gan et al., 2021) in China (Cai et al., 2020) and worldwide (Daugherty et al., 2021; Santana et al., 2022), as evidenced by elevated the alanine aminotransferase and aspartate aminotransferase (Santana et al., 2022). Here, GPT is linked to COVID-19.